Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plasma expander (hydroxyethyl starch) administration in pregnancies with intrauterine growth restriction
2011-003730-13Phase 2Completed
- Sponsor
- Sant'Orsola-Malpighi University Hospital
- Start
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of hetastarch in intrauterine growth restriction (IUGR), sponsored by Sant'Orsola-Malpighi University Hospital. Primary endpoint: Perinatal morbidity and mortality. Started Jul 2012; status: completed.
02
Drugs
hetastarch
03
Conditions
intrauterine growth restriction (IUGR)
Beyond the preview
Go deeper on 2011-003730-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-003730-13.